Deoxymethoxetamine (DMXE): Research Chemical Profile, Effects & Safety

The designer dissociative deoxymethoxetamine (DMXE) is an arylcyclohexylamine research chemical sold online. Deoxymethoxetamine (DMXE) is an arylcyclohexylamine research chemical that has been sold online as a designer dissociative. It is also called 3D-MXE and 3-Me-2′-oxo-PCE. It is also called 3D-MXE and 3-Me-2′-oxo-PCE. Researchers continue to study the chemical properties and pharmacological activity of DMXE because there is limited scientific information available on the substance. Researchers continue to study the chemical properties and pharmacological activity of DMXE because there is limited scientific information available on the substance.

Importantly, DMXE is not an approved treatment or medicine for a medical condition. Importantly, DMXE is not an approved treatment or medicine for a medical condition. So, don’t rely on general descriptions you find online as medical advice. So, don’t rely on general descriptions you find online as medical advice.

What Is Deoxymethoxetamine (DMXE)? What Is Deoxymethoxetamine (DMXE)?

Deoxymethoxetamine is a chemical belonging to the class of chemicals known as arylcyclohexylamines, a family of chemicals that are structurally related to ketamine and methoxetamine. Deoxymethoxetamine is a chemical belonging to the class of chemicals known as arylcyclohexylamines, a family of chemicals that are structurally related to ketamine and methoxetamine. 2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one is its systematic chemical name. 2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one is its systematic chemical name. According to PubChem, its molecular formula is C15H21NO and its molecular weight is ~231.33 g/mol. According to PubChem, its molecular formula is C15H21NO and its molecular weight is ~231.33 g/mol.

DMXE is similar in structure to methoxetamine. DMXE is similar in structure to methoxetamine. However, scientists distinguish between the two compounds as their chemical make-up is not the same. However, scientists distinguish between the two compounds as their chemical make-up is not the same. This structural difference may influence their biological activity. This structural difference may influence their biological activity.

Chemical Profile Chemical Profile

Here are some key identification details: Here are some key identification details:

• Common name: Deoxymethoxetamine Common name: Deoxymethoxetamine
• Abbreviation: DMXE Abbreviation: DMXE
• Other names: 3D-MXE, 3-Me-2′-oxo-PCE Other names: 3D-MXE, 3-Me-2′-oxo-PCE
• Molecular formula: C15H21NO Molecular formula: C15H21NO
• Molecular weight 231.33 g/mol Molecular weight 231.33 g/mol
• Chemical class Arylcyclohexylamines Chemical class Arylcyclohexylamines
• CAS no: 2666932-45-0 CAS no: 2666932-45-0
• IUPAC name 2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one IUPAC name 2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one

## How does DMXE work? ## How does DMXE work?

Studies have demonstrated DMXE can interact with N-methyl-D-aspartate (NMDA) receptors. Studies have demonstrated DMXE can interact with N-methyl-D-aspartate (NMDA) receptors. A laboratory study found that DMXE effectively blocks NMDA receptors. Researchers discovered that DMXE effectively blocks NMDA receptors in a laboratory study. The study determined that the IC50 was approximately 0.679 μM in the tested experimental system. The study determined that the IC50 was approximately 0.679 μM in the experimental system tested.

NMDA receptors play an important role in brain signalling, learning and memory, and excitatory neurotransmission. NMDA receptors play an important role in brain signalling, learning and memory, and excitatory neurotransmission. Therefore , chemicals that interact with these receptors can cause drastic changes in perception and brain function . Therefore , chemicals that interact with these receptors can cause drastic changes in perception and brain function .

But receptor activity in the laboratory doesn’t mean it will have a predictable effect in humans. But receptor activity in the laboratory doesn’t mean it will have a predictable effect in humans. Therefore, further research is needed to fully understand the pharmacological profile of DMXE. Therefore, further research is needed to fully understand the pharmacological profile of DMXE.

Effects and Research Considerations of DMXE Effects and Research Considerations of DMXE

Scientific literature and drug-monitoring literature often describe DMXE as a dissociative new psychoactive substance. Scientific literature and drug-monitoring literature often describe DMXE as a dissociative new psychoactive substance. Researchers have identified DMXE in products that contain arylcyclohexylamine derivatives. Researchers have identified DMXE in products that contain arylcyclohexylamine derivatives.

Limited human clinical research prevents scientists from reliably establishing a complete list of therapeutic benefits or long-term effects. Limited human clinical research prevents scientists from reliably establishing a complete list of therapeutic benefits or long-term effects. Reports on subjective effects should not serve as medical evidence of benefit. Consequently, one should not consider reports on subjective effects as medical evidence of benefit.

Possible safety problems Possible safety problems

This limited research creates an important safety concern. This limited research creates an important safety concern. NMDA receptor activity affects the central nervous system, so unexpected neurologic effects may occur. NMDA receptor activity affects the central nervous system, so unexpected neurologic effects may occur. Products sold under research-chemical names may also differ in purity, composition, or concentration. Products sold under research-chemical names may also differ in purity, composition, or concentration.

A pharmacological study in 2022 has raised concerns about potential harm from strong NMDA receptor blockade by DMXE and related compounds. A pharmacological study in 2022 has raised concerns about potential harm from strong NMDA receptor blockade by DMXE and related compounds.

Therefore, DMXE is not to be considered a proven therapeutic drug or dietary supplement. Therefore, DMXE is not to be considered a proven therapeutic drug or dietary supplement.

DMXE Legal Status DMXE Legal Status

The legal status of DMXE varies widely from country to country, and can change over time. The legal status of DMXE varies widely from country to country, and can change over time. As an example, DMXE is classified as a designated substance in Japan, and enforcement began in July 2022. As an example, DMXE is classified as a designated substance in Japan, and enforcement began in July 2022.

Anyone working with this compound should check their own country’s current regulations and not depend on an old internet listing. Anyone working with this compound should check their own country’s current regulations and not depend on an old internet listing.

FAQs FAQs

DMXE is not a drug. DMXE is not a drug.

None. None. DMXE is not an approved treatment or a recognised prescription medication. DMXE is not an approved treatment or a recognised prescription medication. It is primarily discussed as a research chemical and novel psychoactive substance. It is primarily discussed as a research chemical and novel psychoactive substance.

Is DMXE related to methoxetamine? Is DMXE related to methoxetamine?

Yes. Yes. DMX is chemically similar to methoxetamine, and is a member of the larger class of arylcyclohexylamines. DMXE is chemically similar to methoxetamine, and is a member of the larger class of arylcyclohexylamines.

DMXE has the molecular formula C13H21NO2. DXE has the molecular formula C13H21NO2.

The molecular formula of DMXE is C15H21NO and the molecular weight is about 231.33 g/mol. The molecular formula of DMXE is C15H21NO and the molecular weight is about 231.33 g/mol.

Are there any known medical benefits of DMXE? Are there any known medical benefits of DMXE?

“There is no adequate evidence of medical benefit in humans, in the form of adequate and well-controlled studies.” “There is no adequate evidence of medical benefit in humans, in the form of adequate and well-controlled studies.” The available evidence is mainly chemical identification and laboratory pharmacology. The available evidence is mainly chemical identification and laboratory pharmacology.

Summary Summary

Deoxymethoxetamine (DMXE) is a rare arylcyclohexylamine research compound with limited data on human safety and pharmacology. Deoxymethoxetamine (DMXE) is a rare arylcyclohexylamine research compound with limited data on human safety and pharmacology. Studies have found it to have a high affinity for NMDA receptors, which explains its classification as a dissociative new psychoactive substance by researchers. Studies have found it to have a high affinity for NMDA receptors, which explains its classification as a dissociative new psychoactive substance by researchers.

In light of limited evidence, responsible scientific discussion should focus on its chemistry, receptor activity, research status and potential risks and not treat it as a proven medicine or wellness product. In light of limited evidence, responsible scientific discussion should focus on its chemistry, receptor activity, research status and potential risks and not treat it as a proven medicine or wellness product.